Hypoxia-induced cell death in human malignant glioma cells: Energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death

Cell Death and Differentiation

Volumn 10, Issue 7, 2003, Pages 823-832

  Steinbach, Joachim P ^a   Wolburg, H ^b   Klumpp, A ^a   Probst, H ^b   Weller, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; ATP; BCL X; Caspase; Cytochrome c; Glioma; Hypoxia; Necrosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS INHIBITOR; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; DNA FRAGMENT; GLUCOSE; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; BIOCHEMISTRY; CANCER CELL CULTURE; CELL DEATH; CELL ENERGY; CELL HYPOXIA; CELL PROTECTION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENERGY RESOURCE; ENZYME DEGRADATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; NERVE CELL NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION;

ADENOSINE TRIPHOSPHATE; BCL-X PROTEIN; BIOLOGICAL RESPONSE MODIFIERS; BRAIN NEOPLASMS; CASPASES; CELL DEATH; CELL HYPOXIA; CELL NUCLEUS; CYTOCHROMES C; CYTOPLASM; ENERGY METABOLISM; GLIOMA; GLUCOSE; HUMANS; MICROSCOPY, ELECTRON; MITOCHONDRIA; NECROSIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STARVATION; TUMOR CELLS, CULTURED; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0038494535     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401252     Document Type: Article

References (54)

1. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29: 427-431
2. Valk PE, Mathis CA, Prados MD, Gilbert JC and Budinger TF (1992) Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J. Nucl. Med. 33: 2133-2137
3. Collingridge DR, Piepmeier JM, Rockwell S and Knisely JP (1999) Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother. Oncol. 53: 127-131
4. Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ, Zabski S, Yancopoulos GD and Grumet M (2000) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab. Invest. 80: 837-849
5. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD and Wiegand SJ (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1998
6. Royds JA, Dower SK, Qwarnstrom EE and Lewis CE (1998) Response of tumour cells to hypoxia: role of p53 and NFkB. Mol. Pathol. 51: 55-61
7. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H and Cavenee WK (2000) Glioblastoma. In Pathology and Genetics of Tumours of the Nervous System, Kleihues P and Cavenee WK (eds) (Lyon: IARC Press) pp. 29-39
8. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K and Dewhirst MW (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 56: 5522-5528
9. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3: 177-182
10. Read TA, Sorensen DR, Mahesparan R, Enger PO, Timpl R, Olsen BR, Hjelstuen MH, Haraldseth O and Bjerkvig R (2001) Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 19: 29-34
11. Machein MR, Risau W and Plate KH (1999) Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2. Hum. Gene Ther. 10: 1117-1128
12. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91
13. Araya R, Uehara T and Nomura Y (1998) Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett. 439: 168-172
14. Amellem O, Stokke T, Sandvik JA, Smedshammer L and Pettersen EO (1997) Hypoxia-induced apoptosis in human cells with normal p53 status and function, without any alteration in the nuclear protein level. Exp. Cell Res. 232: 361-370
15. Saikumar P, Dong Z, Weinberg JM and Venkatachalam MA (1998) Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17: 3341-3349
16. Tohma Y, Gratas C, Van Meir EG, Desbaillets I, Tenan M, Tachibana O, Kleihues P and Ohgaki H (1998) Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas. J. Neuropathol. Exp. Neurol. 57: 239-245
17. Steinbach JP and Weller M (2002) Mechanisms of apoptosis in CNS tumors: application to theory. Curr. Neurol. Neurosci. Rep. 2: 246-253
18. Tachibana O, Lampe J, Kleihues P and Ohgaki H (1996) Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme. Acta Neuropathol. 92: 431-434
19. Schiffer D, Cavalla P, Migheli A, Chio A, Giordana MT, Marino S and Attanasio A (1995) Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci. Lett. 195: 81-84
20. Plate KH, Breier G, Weich HA and Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848
21. Dong Z, Venkatachalam MA, Wang J, Patel Y, Saikumar P, Semenza GL, Force T and Nishiyama J (2001) Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J. Biol. Chem. 276: 18702-18709
22. Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG, DiPaolo JA, Peehl DM and Giaccia AJ (1997) Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res. 57: 4200-4204
23. Teicher BA (1994) Hypoxia and drug resistance. Cancer Metast Rev. 13: 139-168
24. Hockel M, Vorndran B, Schlenger K, Baussmann E and Knapstein PG (1993) Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol. Oncol. 51: 141-149
25. Korshunov A, Golanov A, Sycheva R and Pronin I (1999) Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. J. Clin. Pathol. 52: 574-580
26. Rhodes RH (1998) Biological evaluation of biopsies from adult cerebral astrocytomas: cell-growth/cell-suicide ratios and their relationship to patient survival. J. Neuropathol. Exp. Neurol. 57: 746-757
27. Hossmann KA, Mies G, Paschen W, Szabo L, Dolan E and Wechsler W (1986) Regional metabolism of experimental brain tumors. Acta Neuropathol 69: 139-147
28. Mies G, Paschen W, Ebhardt G and Hossmann KA (1990) Relationship between blood flow, glucose metabolism, protein synthesis, glucose and ATP content in experimentally induced glioma (RG1 2.2) of rat brain. J. Neurooncol. 9: 17-28
29. Vaupel P (1992) Physiological properties of malignant tumours. NMR Biomed 5: 220-225
30. Leist M, Single B, Castoldi AF, Kuhnle S and Nicotera P (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185: 1481-1486
31. Eguchi Y, Shimizu S and Tsujimoto Y (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57: 1835-1840
32. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y and Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964
33. Glaser T, Wagenknecht B, Groscurth P, Krammer PH and Weller M (1999) Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells. Oncogene 18: 5044-5053
34. Hermisson M, Wagenknecht B, Wolburg H, Glaser T, Dichgans J and Weller M (2000) Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release. Oncogene 19: 2338-2345
35. Gerweck LE, Seneviratne T and Gerweck KK (1993) Energy status and radiobiological hypoxia at specified oxygen concentrations. Radiat Res 135: 69-74
36. Glaser T, Wagenknecht B and Weller M (2001) Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Oncogene 20: 4757-4767
37. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM and Venkatachalam MA (1998) Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 17: 3401-3415
38. Callahan DJ, Engle MJ and Volpe JJ (1990) Hypoxic injury to developing glial cells: protective effect of high glucose. Pediatr. Res. 27: 186-190
39. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X (1997) cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489
40. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9- dependent manner. J. Cell Biol. 144: 281-292
41. Eguchi Y, Srinivasan A, Tomaselli KJ, Shimizu S and Tsujimoto Y (1999) ATP-dependent steps in apoptotic signal transduction. Cancer Res. 59: 2174-2181
42. Wagenknecht B, Glaser T, Naumann U, Kugler S, Isenmann S, Bahr M, Korneluk R, Liston P and Weller M (1999) Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 6: 370-376
43. Weller M, Rieger J, Grimmel C, Van Meir EG, De Tribolet N, Krajewski S, Reed JC, von Deimling A and Dichgans J (1998) Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int. J. Cancer 79: 640-644
44. Leist M and Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2: 589-598
45. Wang KK (2000) Calpain and caspase: can you tell the difference? Trends Neurosci 23: 20-26
46. Waterhouse NJ, Finucane DM, Green DR, Elce JS, Kumar S, Alnemri ES, Litwack G, Khanna K, Lavin MF and Watters DJ (1998) Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ 5: 1051-1061
47. Haraguchi M, Torii S, Matsuzawa S, Xie Z, Kitada S, Krajewski S, Yoshida H, Mak TW and Reed JC (2000) Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J Exp Med 191: 1709-1720
48. Green DR and Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309-1312
49. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC and Kroemer G (2000) Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571-580
50. Reed JC (1997) cytochrome c: can't live with it-can't live without it. Cell 91: 559-562
51. Roth W, Fontana A, Trepel M, Reed JC, Dichgans J and Weller M (1997) Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. Cancer Immunol. Immunother. 44: 55-63
52. Probst H, Schiffer H, Gekeler V, Kienzle Pfeilsticker H, Stropp U, Stotzer KE and Frenzel-Stotzer I (1988) Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and in vivo. Cancer Res. 48: 2053-2060
53. Dreier T, Scheidtmann KH and Probst H (1993) Synchronous replication of SV 40 DNA in virus infected TC 7 cells induced by transient hypoxia. FEBS Lett. 336: 445-451
54. Kendler A and Dawson G (1990) Progressive hypoxia inhibits the de novo synthesis of galactosylceramide in cultured oligodendrocytes. J Biol Chem 265: 12259-12266